Chronic myeloid leukemia with increased granulocyte progenitors in mice lacking JunB expression in the myeloid lineage

Cell

Volumn 104, Issue 1, 2001, Pages 21-32

  Passegué, Emmanuelle ^a   Jochum, Wolfram ^a   Schorpp Kistner, Marina ^b   Möhle Steinlein, Uta ^a   Wagner, Erwin F ^a  

^a RESEARCH INSTITUTE OF MOLECULAR PATHOLOGY   (Austria)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GROWTH FACTOR; INTERLEUKIN 3; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLAST CELL; CELL DIFFERENTIATION; CHRONIC MYELOID LEUKEMIA; GENE EXPRESSION; GENE OVEREXPRESSION; GRANULOCYTE PRECURSOR; HEMATOPOIETIC STEM CELL; LIVER CELL; MOUSE; MYELOPOIESIS; MYELOPROLIFERATIVE DISORDER; NONHUMAN; ONCOGENE C JUN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; TRANSCRIPTION REGULATION; TRANSGENIC MOUSE; TUMOR SUPPRESSOR GENE;

ANIMALIA; MUS MUSCULUS;

EID: 0035846912     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(01)00188-X     Document Type: Article

References (37)

1. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages
2. The role of Jun, Fos and the AP-1 complex in cell proliferation and transformation
3. The structural and functional basis of cytokine receptor activation: Lesson from the common beta subunit of the granulocyte-macrophage colony-stimuling factor, interleukin-3 (IL-3), and IL-5 receptors
4. Cell cycle-dependent variations in c-Jun and JunB phosphorylation: A role in the control of cyclinD1 expression
5. c-Jun is a JNK-independent coactivator of the PU.1 transcription factor
6. Jun-B differs in its biological properties from, and is a negative regulator of, c-Jun
7. Dysregulated hematopoiesis and a progressive neurological disorder induced by expression of an activated form of the human common beta chain in transgenic mice
8. Activities of granulocyte-macrophage colony-stimulating factor revealed by gene transfer and gene knockout studies
9. The hallmarks of cancer
10. Acute leukaemia in bcr/abl transgenic mice
11. Targeted disruption of SHIP leads to hematopoietic perturbations, lung pathology, and shortened life span
12. Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice with targetd mutation of the ICSBP gene
13. Promoter-specific transactivation and inhibition mediated by JunB
14. A lethal myeloproliferative syndrome in mice transplanted with bone marrow cells infected with a retrovirus expressing granulocyte-macrophage colony stimulating factor
15. Identification and functional characterization of a Smad binding element (SBE) in the JunB promoter that acts as a transforming growth factor-beta, activin, and bone morphogenetic protein-inducible enhancer
16. AP-1 function and regulation
17. Hematopoietic commitment during embryonic stem cell differentiation in culture
18. Antiapoptotic activity of Stat5 required during terminal stages of myeloid differentiation
19. bcl-2 inhibits apoptosis of neutrophils but not their engulfment by macrophages
20. Flow cytometric identification of murine neutrophils and monocytes
21. Nf1 deficiency causes Ras-mediated granulocyte/macrophage colony-stimulating factor hypersensitivity and chronic myeloid leukaemia
22. Smads bind directly to the Jun family of AP-1 transcription factors
23. MyD genes in negative growth control
24. Impaired production and increased apoptosis of neutrophils in granulocyte colony-stimulating factor receptor-deficient mice
25. Proto-oncogenes of the fos/jun family of transcription factors are positive regulators of myeloid differentiation
26. Fosl1 is a transcriptional target of c-Fos during osteoclast differentiation
27. Expression of c-jun, junB and junD proto-oncogenes in human peripheral-blood granulocytes
28. INK4a expression
29. Chronic myeloid leukemia
30. The human ubiquitin C promoter directs high ubiquitous expression of transgenes in mice
31. JunB is essential for mammalian placentation
32. Control of cell cycle progression by c-Jun is p53 dependent
33. Interleukin-6 and leukemia inhibitory factor induction of JunB is regulated by distinct cell type-specific cis-acting elements
34. c-Jun and JunB antagonistically control cytokine-regulated mesenchymal-epidermal interaction in skin
35. Mice defective in two apoptosis pathways in the myeloid lineage develop acute myeloblastic leukemia
36. Transcription factors, normal myeloid development, and leukemia
37. Generation of completely embryonic stem cell-derived mutant mice using tetraploid blastocyst injection